688271 联影医疗
2024/09 - 九个月
人民幣(K¥)
与去年同期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)
营业总收入6,954,283-6.43%11,410,7669,238,1237,253,7565,761,034
减:营业总成本6,608,290-1.81%9,857,9467,774,1816,004,1984,933,173
    其中:营业成本3,518,012-7.79%5,878,5814,769,9983,668,5992,960,319
               财务费用(60,910)-54.83%(148,887)(98,725)(24,430)24,291
               资产减值损失50,456-1,199.86%(42,886)(74,747)(25,198)(6,671)
公允价值变动收益635-111.45%(6,063)28,500(10,588)4,906
投资收益72,237-11.05%110,34512,66762,25028,813
    其中:对联营企业和合营企业的投资收益(9,114)-23.35%(15,872)(7,651)(3,055)(9,738)
营业利润717,190-38.38%2,141,5151,928,2431,696,1321,180,797
利润总额711,860-38.97%2,142,2551,919,7951,697,5431,155,006
减:所得税费用53,471-46.99%164,500269,710294,033218,362
净利润658,390-38.21%1,977,7551,650,0861,403,509936,645
减:非控股权益(12,774)-1,099.91%3,462(5,998)(13,675)33,729
股东净利润671,163-36.94%1,974,2921,656,0841,417,185902,916

市场价值指针
每股收益 (元) *0.820-36.43%2.4002.1901.9601.300
每股派息 (元) *0.120--0.2500.201----
每股净资产 (元) *23.3276.85%22.89221.2146.9604.970
审计意见 #--标准无保留意见标准无保留意见标准无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容